Refludan® for the treatment of heparin-induced thrombocytopenia type II and thromboembolic disease in adults mandating parenteral antithrombin therapy - an infrequent but potentially life-threatening response to heparin therapy
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment